z-logo
open-access-imgOpen Access
P113 (0040) PHASE I/II STUDY OF BRENTUXIMAB VEDOTIN IN FIRST REFRACTORY/RELAPSED CLASSICAL HODGKIN LYMPHOMA PATIENTS TREATED BY CHEMOTHERAPY (ICE) BEFORE AUTOLOGOUS TRANSPLANTATION
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547958.28876.fd
Subject(s) - brentuximab vedotin , medicine , refractory (planetary science) , lymphoma , chemotherapy , oncology , transplantation , surgery , hodgkin lymphoma , metallurgy , materials science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here